SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-20-000081
Filing Date
2020-07-16
Accepted
2020-07-16 20:56:38
Documents
2
Period of Report
2020-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159494738307174.html 4  
1 FORM 4 wf-form4_159494738307174.xml 4 3921
2 EX-24 DOCUMENT DAVID ARTHUR salarius-section16powerofa.htm EX-24 10584
  Complete submission text file 0001615219-20-000081.txt   15985
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2450 HOLCOME BLVD. SUITE J-608 HOUSTON TX 77021
Business Address
Arthur David J. (Reporting) CIK: 0001769331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 201032604